AstraZeneca, Daiichi Sankyo get U.S. breakthrough therapy status for Enhertu AstraZeneca, Daiichi Sankyo get U.S. breakthrough therapy status for Enhertu Post ContentaznRead More You might also be interested in reading Hyperion DeFi appoints former PayPal exec as CFO. July 17, 2025 In Mainstream ← Previous post Next post →